Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer Mar 17, 2025 07:38AM
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference Sep 21, 2023 08:30AM
PAVmed Provides Business Update and Third Quarter 2022 Financial Results Nov 15, 2022 04:20PM
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results Nov 14, 2022 04:40PM
Cantor Fitzgerald Reiterates Overweight Rating, $5 on PAVmed (PAVM), "Encourage Investors to Acquire PAVM Shares at Attractive Valuation" May 13, 2022 06:10AM


May 12, 2022 04:38PM PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
May 11, 2022 04:00PM Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
Mar 30, 2022 06:19AM Cantor Fitzgerald Lowers PT to $5, Reiterates Overweight Rating on PAVmed (PAVM)
Mar 29, 2022 04:11PM PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Mar 28, 2022 04:50PM Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
Mar 28, 2022 04:47PM Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Oct 18, 2021 06:09PM Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Oct 18, 2021 05:45PM Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Oct 18, 2021 05:45PM Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Oct 13, 2021 10:15PM Lucid Diagnostics Announces Pricing of Initial Public Offering
Oct 13, 2021 10:15PM Lucid Diagnostics Announces Pricing of Initial Public Offering
Oct 13, 2021 09:28PM Lucid Diagnostics Announces Pricing of Initial Public Offering
Sep 23, 2021 09:30AM PAVmed's (PAVM) Lucid Diagnostics Files For a Proposed IPO
Sep 23, 2021 09:30AM PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
Sep 7, 2021 10:04AM PAVmed to Participate in September Investor and MedTech Conferences
May 17, 2021 04:00PM PAVmed Provides Business Update and First Quarter 2021 Financial Results
Mar 30, 2021 09:21AM Pre-Open Stock Movers 03/30: (MBRX) (ABCL) (SEEL) Higher; (WVE) (BFLY) (CLDX) Lower (more...)
Mar 29, 2021 05:32PM After-Hours Stock Movers 03/29: (BIOC) (SEAC) (NOVN) Higher; (WVE) (BFLY) (CLDX) Lower (more...)
Mar 29, 2021 04:38PM UPDATE: Cantor Fitzgerald Starts PAVmed (PAVM) at Overweight
Feb 25, 2021 12:37PM PAVmed Announces Closing of its Public Offering of Common Stock
Feb 23, 2021 09:03AM PAVmed (PAVM) Prices 9.8M Share Common Offering for Gross Proceeds of Approx. $45M
Feb 23, 2021 09:00AM PAVmed Announces Pricing of $45 Million Public Offering of Common Stock
Feb 22, 2021 04:14PM PAVmed (PAVM) to Offer Common Stock
Feb 22, 2021 04:13PM PAVmed Announces Proposed Public Offering of Common Stock
Sep 8, 2020 09:30AM PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
Sep 18, 2017 07:30AM PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference